Mobile
Recherche simple
Recherche avancée
Recherche multicritère
Qui sommes-nous ?
Connexion
Inscription
French
English
Kusajili – Centralise les essais cliniques mondiaux
Envoyer cette étude a un contact
1
Vos informations personnelles
Votre nom
Votre email
M'envoyer une copie
2
Les informations de votre destinataire
Le nom de votre contact
L'email de votre contact
3
Votre message
Votre message
A study comparing the treatment benefits of MPDL32018 used alone and used together with Avastin to Sunitinb. Benefit is being studied in patients who have advanced kidney cancer or kidney cancer which has spread to other parts of the body and has not been treated before. Acesta este un studiu de faza II, multicentric, randomizat, cu etichetă vizibilă, conceput pentru a estima eficacitatea MPDL3280A + bevacizumab şi a MPDL3280A monoterapie faţă de sunitinib la pacienţii cu RCC confirmat histologic, inoperabil, avansat local sau metastatic, care nu au beneficiat anterior de terapie sistemică nici în contextul adjuvant, nici în cel metastatic https://kusajili.fr:443/Trial/UzlesiQR7kq9qw4mQ88hTw%24a-study-comparing-the-treatment-benefits-of-mpdl32018-used-alone-and-used-together-with-avastin-to-sunitinb-benefit-is-being-st
J’ai lu et j’accepte les conditions d’utilisation du site et la Politique de protection des données personnelles
Envoyer votre message